Shankar Venkatraman

2.9k total citations · 1 hit paper
22 papers, 2.0k citations indexed

About

Shankar Venkatraman is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Shankar Venkatraman has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Shankar Venkatraman's work include Computational Drug Discovery Methods (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Peptidase Inhibition and Analysis (3 papers). Shankar Venkatraman is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Peptidase Inhibition and Analysis (3 papers). Shankar Venkatraman collaborates with scholars based in United States, Canada and Switzerland. Shankar Venkatraman's co-authors include Jason D. Katz, Alexiane Decout, Andrea Ablasser, Jing Yuan, Lawrence W. Dillard, Brian M. McKeever, Suresh B. Singh, Ya‐Jun Zheng, Rodney L. Johnson and Gregg Wesolowski and has published in prestigious journals such as Nature reviews. Immunology, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Shankar Venkatraman

22 papers receiving 1.9k citations

Hit Papers

The cGAS–STING pathway as... 2021 2026 2022 2024 2021 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The cGAS–STING pathway as a therapeutic target in inflammatory diseases
    2021 1.4k citations Alexiane Decout, Jason D. Katz et al. Nature reviews. Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shankar Venkatraman United States 11 1.1k 995 302 208 192 22 2.0k
Terence G. Porter United States 13 733 0.7× 605 0.6× 113 0.4× 229 1.1× 103 0.5× 16 1.7k
Chih‐Chi Andrew Hu United States 25 1.0k 1.0× 605 0.6× 196 0.6× 242 1.2× 186 1.0× 54 2.1k
Sunghyun Kang South Korea 26 1.4k 1.3× 326 0.3× 105 0.3× 376 1.8× 151 0.8× 64 2.1k
Hidekazu Sawada Japan 11 602 0.6× 411 0.4× 271 0.9× 245 1.2× 61 0.3× 25 1.3k
Robert W. Marquis United States 19 1.9k 1.8× 732 0.7× 80 0.3× 429 2.1× 319 1.7× 30 2.5k
Martin K. Bijsterbosch Netherlands 25 1.0k 1.0× 452 0.5× 43 0.1× 225 1.1× 255 1.3× 46 1.9k
Masashi Morita Japan 21 1.6k 1.4× 334 0.3× 95 0.3× 389 1.9× 214 1.1× 89 2.1k
Stavroula Baritaki Greece 31 1.5k 1.4× 492 0.5× 98 0.3× 715 3.4× 571 3.0× 96 2.6k
Jason D. Katz United States 12 946 0.9× 994 1.0× 292 1.0× 213 1.0× 136 0.7× 23 1.9k
Stefan Müller Germany 28 1.6k 1.5× 488 0.5× 61 0.2× 262 1.3× 186 1.0× 51 2.4k

Countries citing papers authored by Shankar Venkatraman

Since Specialization
Citations

This map shows the geographic impact of Shankar Venkatraman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shankar Venkatraman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shankar Venkatraman more than expected).

Fields of papers citing papers by Shankar Venkatraman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shankar Venkatraman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shankar Venkatraman. The network helps show where Shankar Venkatraman may publish in the future.

Co-authorship network of co-authors of Shankar Venkatraman

This figure shows the co-authorship network connecting the top 25 collaborators of Shankar Venkatraman. A scholar is included among the top collaborators of Shankar Venkatraman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shankar Venkatraman. Shankar Venkatraman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Decout, Alexiane, Jason D. Katz, Shankar Venkatraman, & Andrea Ablasser. (2021). The cGAS–STING pathway as a therapeutic target in inflammatory diseases. Nature reviews. Immunology. 21(9). 548–569. 1401 indexed citations breakdown →
2.
Dorner‐Ciossek, Cornelia, Scott Hobson, Klaus Fuchs, et al.. (2015). P1‐314: Pharmacological characterization of the new bace1 inhibitor bi 1181181. Alzheimer s & Dementia. 11(7S_Part_10). 2 indexed citations
3.
Yuan, Jing, Shankar Venkatraman, Ya‐Jun Zheng, et al.. (2013). Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer’s Disease. Journal of Medicinal Chemistry. 56(11). 4156–4180. 111 indexed citations
4.
Venkatraman, Shankar, et al.. (2010). Antibacterial activity of Vicoa indica and Tridax procumbens against Multi-Drug Resistant (MDR) clinical isolates. 3(4). 163–168. 1 indexed citations
5.
Venkatraman, Shankar, Alec D. Lebsack, Michael F. Gardner, et al.. (2009). Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(l)-prolyl}-4-[(3′,5′-dichloro-isonicotinoyl) amino]-(l)-phenylalanine (MK-0617), a highly potent and orally active VLA-4 antagonist. Bioorganic & Medicinal Chemistry Letters. 19(19). 5803–5806. 6 indexed citations
6.
Smith, Sean M., Jason M. Uslaner, Lihang Yao, et al.. (2008). The Behavioral and Neurochemical Effects of a Novel d-Amino Acid Oxidase Inhibitor Compound 8 [4 H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and d-Serine. Journal of Pharmacology and Experimental Therapeutics. 328(3). 921–930. 73 indexed citations
7.
Sparey, Tim, Pravien Abeywickrema, Sarah Almond, et al.. (2008). The discovery of fused pyrrole carboxylic acids as novel, potent d-amino acid oxidase (DAO) inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(11). 3386–3391. 63 indexed citations
8.
Setti, Eduardo L., Shankar Venkatraman, James T. Palmer, et al.. (2006). Design and synthesis of tetracyclic nonpeptidic biaryl nitrile inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 16(16). 4296–4299. 8 indexed citations
9.
Venkatraman, Shankar, Jongwon Lim, Merryl Cramer, et al.. (2005). Influence of acid surrogates toward potency of VLA-4 antagonist. Bioorganic & Medicinal Chemistry Letters. 15(18). 4053–4056. 6 indexed citations
10.
Lebsack, Alec D., Janet L. Gunzner, Bowei Wang, et al.. (2004). Identification and synthesis of [1,2,4]triazolo[3,4-a]phthalazine derivatives as high-affinity ligands to the α2δ-1 subunit of voltage gated calcium channel. Bioorganic & Medicinal Chemistry Letters. 14(10). 2463–2467. 29 indexed citations
11.
Lim, Jongwon, Nicholas Stock, Richard Pracitto, et al.. (2004). N-Acridin-9-yl-butane-1,4-diamine derivatives: high-affinity ligands of the α2δ subunit of voltage gated calcium channels. Bioorganic & Medicinal Chemistry Letters. 14(8). 1913–1916. 10 indexed citations
12.
Falgueyret, Jean‐Pierre, W. Cameron Black, Wanda Cromlish, et al.. (2004). An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells. Analytical Biochemistry. 335(2). 218–227. 45 indexed citations
13.
Hu, Tao, Brian A. Stearns, Brian T. Campbell, et al.. (2004). Synthesis and biological evaluation of 6-aryl-6 H -pyrrolo[3,4- d ]pyridazine derivatives as high-affinity ligands of the α 2 δ subunit of voltage-gated calcium channels. Bioorganic & Medicinal Chemistry Letters. 14(9). 2031–2034. 13 indexed citations
14.
Robichaud, Joël, Renata M. Oballa, Peppi Prasit, et al.. (2003). A Novel Class of Nonpeptidic Biaryl Inhibitors of Human Cathepsin K. Journal of Medicinal Chemistry. 46(17). 3709–3727. 66 indexed citations
15.
Mendonca, Rohan, Shankar Venkatraman, & James T. Palmer. (2002). Novel route to the synthesis of peptides containing 2-amino-1′-hydroxymethyl ketones and their application as cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(20). 2887–2891. 7 indexed citations
16.
Murray, Michael A., James W. Janc, Shankar Venkatraman, & Lilia M. Babé. (2001). Peptidyl Diazomethyl Ketones Inhibit the Human Rhinovirus 3C Protease: Effect on Virus Yield by Partial Block of P3 Polyprotein Processing. Antiviral chemistry & chemotherapy. 12(5). 273–281. 3 indexed citations
17.
Evans, Margaret C., Ashish Pradhan, Shankar Venkatraman, et al.. (1999). Synthesis and Dopamine Receptor Modulating Activity of Novel Peptidomimetics ofl-Prolyl-l-leucyl-glycinamide Featuring α,α-Disubstituted Amino Acids. Journal of Medicinal Chemistry. 42(8). 1441–1447. 44 indexed citations
18.
Tokar, Christopher J., Shankar Venkatraman, Robert J. Roon, et al.. (1999). Cyclobutane Quisqualic Acid Analogues as Selective mGluR5a Metabotropic Glutamic Acid Receptor Ligands. Journal of Medicinal Chemistry. 42(9). 1639–1647. 10 indexed citations
19.
Venkatraman, Shankar, Kelly Furness, Sanjay Nimkar, et al.. (1998). Synthesis and Evaluation of Peptidyl Michael Acceptors That Inactivate Human Rhinovirus 3C Protease and Inhibit Virus Replication. Journal of Medicinal Chemistry. 41(14). 2579–2587. 46 indexed citations
20.
Venkatraman, Shankar, Robert J. Roon, Marvin K. Schulte, James F. Koerner, & Rodney L. Johnson. (1994). Synthesis of Oxadiazolidinedione Derivatives as Quisqualic Acid Analogs and Their Evaluation at a Quisqualate-Sensitized Site in the Rat Hippocampus. Journal of Medicinal Chemistry. 37(23). 3939–3946. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terence G. Porter Breakdown of academic impact, for papers by Chih‐Chi Andrew Hu Breakdown of academic impact, for papers by Sunghyun Kang Breakdown of academic impact, for papers by Hidekazu Sawada Breakdown of academic impact, for papers by Robert W. Marquis Breakdown of academic impact, for papers by Martin K. Bijsterbosch Breakdown of academic impact, for papers by Masashi Morita Breakdown of academic impact, for papers by Stavroula Baritaki Breakdown of academic impact, for papers by Jason D. Katz Breakdown of academic impact, for papers by Stefan Müller
Rankless by CCL
2026